Acquisitions and Divestitures (Tables)

12 Months Ended

Dec. 31, 2021

Business Combinations [Abstract]

Schedule of Components of Routine Acquisitions

During 2021, 2020, and 2019 the Company acquired dialysis businesses and other businesses, including a transplant software company, as follows:

	Year ended Year ended December 31,
	2021		2020		2019
Cash paid, net of cash acquired	$	187,050	$	182,013	$	98,836
Contingent earn-out obligations	14,854		14,042		23,536
Deferred purchase price and liabilities assumed	10,226		20,415		4,326
Non-cash gain	—		1,821		—
Aggregate consideration	$	212,130	$	218,291	$	126,698
Number of dialysis centers acquired — U.S.	19		8		7
Number of dialysis centers acquired — International	17		66		16

Aggregate Purchase Cost Allocations for Acquisitions

The following table summarizes the assets acquired and liabilities assumed in these transactions and recognized at their acquisition dates at estimated fair values, as well as the estimated fair value of noncontrolling interests assumed in these transactions:

	Year ended December 31,
	2021		2020		2019
Current assets	$	9,134	$	23,607	$	6,713
Property and equipment	9,277		37,457		4,842
Customer relationships	17,200		34,625		—
Noncompetition agreements and other long-term assets	9,964		10,168		1,980
Indefinite-lived licenses	11,432		22,136		31,858
Goodwill	173,244		130,057		90,226
Deferred income taxes	—		(3,962)		—
Liabilities assumed	(14,200)		(34,068)		(7,159)
Noncontrolling interests assumed	(3,921)		(1,729)		(1,762)
	$	212,130	$	218,291	$	126,698

Schedule of other information related to acquired intangibles and goodwill

The following summarizes weighted-average estimated useful lives of amortizable intangible assets acquired during 2021, 2020 and 2019, as well as goodwill deductible for tax purposes associated with these acquisitions:

	Year ended December 31,
	2021		2020		2019
Weighted-average estimated useful lives (in years):
Customer relationships	10		18
Noncompetition agreements	6		5		6
Goodwill deductible for tax purposes	$	169,014	$	94,318	$	88,517

Pro Forma Summary of Results of Operations

The following summary, prepared on a pro forma basis, combines the results of operations as if all acquisitions within continuing operations in 2021 and 2020 had been consummated as of the beginning of 2020, including the impact of certain adjustments such as amortization of intangibles, interest expense on acquisition financing and income tax effects.

	Year ended December 31,
	2021		2020
	(unaudited)
Pro forma total revenues	$	11,678,798	$	11,722,511
Pro forma net income from continuing operations attributable to  DaVita Inc.	$	985,800	$	797,844
Pro forma basic net income per share from continuing operations  attributable to DaVita Inc.	$	9.37	$	6.66
Pro forma diluted net income per share from continuing operations  attributable to DaVita Inc.	$	8.97	$	6.51

Reconciliation of Changes in Contingent Earn-Out Obligations

The following is a reconciliation of changes in contingent earn-out liabilities for the years ended December 31, 2021 and 2020: 

	Year ended December 31,
	2021		2020
Beginning balance	$	30,248	$	24,586
Acquisitions	14,854		14,042
Foreign currency translation	(1,674)		(3,688)
Fair value remeasurements	(1,292)		(2,630)
Payments or other settlements	(8,536)		(2,062)
Ending balance	$	33,600	$	30,248